An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
Medical Xpress – latest medical and health news stories
Posted inHealth Care
Enzyme study unveils key strategies against drug-resistant prostate cancer
Posted by
No Comments
No Comments
